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AbstrACt
Introduction The South African Department of Health 
has developed and implemented the Integrated Chronic 
Disease Management (ICDM) model to respond to the 
increased utilisation of primary healthcare services due 
to a surge of non-communicable diseases coexisting with 
a high prevalence of communicable diseases. However, 
some of the expected outcomes on implementing the 
ICDM model have not been achieved. The aims of this 
study are to assess if the observed suboptimal outcomes 
of the ICDM model implementation are due to lack of 
fidelity to the ICDM model, to examine the contextual 
factors associated with the implementation fidelity and to 
calculate implementation costs.
Methods and analysis A process evaluation, mixed 
methods study in 16 pilot clinics from two health districts 
to assess the degree of fidelity to four major components 
of the ICDM model. Activity scores will be summed per 
component and overall fidelity score will be calculated by 
summing the various component scores and compared 
between components, facilities and districts. The 
association between contextual factors and the degree 
of fidelity will be asseseed by multivariate analysis, 
individual and team characteristics, facility features and 
organisational culture indicators will be included in the 
regression. Health system financial and economic costs 
of implementing the four components of the ICDM model 
will be calculated using an ingredient approach. The unit 
of implementation costs will be by activity of each of the 
major components of the ICDM model. Sensitivity analysis 
will be carried out using clinic size, degree of fidelity and 
different inflation situations.
Ethics and dissemination The protocol has been 
approved by the University of Cape Town and University of 
the Witwatersrand Human Research ethics committees. 
The results of the study will be shared with the 
Department of Health, participating health facilities 
and through scientific publications and conference 
presentations.
IntroduCtIon
Chronic diseases and multimorbidity 
are increasing in developing countries due 
to epidemiological transition of increasing 
prevalence of non-communicable diseases 
(NCDs) in the presence of rampant infectious 
diseases.1 2 By 2025, it is estimated that the 
burden of NCDs in sub-Saharan Africa will be 
higher than that of communicable diseases 
(CDs).3 The increase in urbanisation, 
economic development, ageing, decrease 
in physical activity and poor dietary options 
are some of the contributing factors to the 
increasing prevalence of NCDs in developing 
countries.4 5 There is also a complex interac-
tion of risk factors, management and health 
outcomes between NCDs and CDs, resulting 
in a rise in chronic disease multimorbidity.6 7 
Multimorbidity often results in reduced levels 
of physical capability, high rates of health 
services utilisation and attendant costs and 
higher mortality rates.8 9 The double burden 
(NCDs and CDs) of diseases is costly to the 
health systems (increased utilisation, medi-
cation), the economies, households and 
individuals.2 Therefore, chronic disease 
strengths and limitations of this study
 ► This study uses implementation research princi-
ples to provide data on the degree of fidelity to the 
Integrated Chronic Disease Management (ICDM) 
model for optimising the model.
 ► Process evaluation will provide an indication of how 
the ICDM model has been modified in different con-
texts and explain variability in the implementation 
outcomes.
 ► Implementation cost assessments are essential in 
public health programmes to inform resource allo-
cation during planning and budgeting and to inform 
economic evaluations.
 ► The reliance on the service provider to accurately 
provide information on the implementation activities 
or insufficiencies of those activities is a limitation of 
this study.
 ► Although the clinics may not be representative of all 
districts and clinics in the country, the results of this 
study could be applied to clinics similar in size or 
patient load and other integrated disease manage-
ment models.
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management needs to be comprehensive and take into 
consideration these interactions in disease prevention, 
management and control.
In South Africa, the current leading health problems 
are NCDs, accounting for 51.3% of all deaths, followed 
by CDs 38.4% and injuries 10.3%.10 South Africa like 
many Sub-Saharan African countries has been severely 
affected by the HIV/AIDS epidemic, with 7.1 million 
people living with HIV and 18.9% of people between the 
ages of 15 and 49 years being HIV infected.11 As a result, 
there is an increase in the prevalence of multimorbidity.12 
Tuberculosis, HIV and NCDs (mainly hypertension and 
diabetes mellitus) account for 45% of all primary health-
care consultations, with a multimorbidity prevalence of 
22.6%.9 13
Unresponsive health systems often provide services 
that are not aligned with the health requirements of 
the population being served.14 A more comprehen-
sive chronic disease management model, combining 
both CDs and NCDs that reduces health utilisation and 
promotes self-management, is one of the strategies that 
have been recommended to address the challenges asso-
ciated with the management of multimorbid chronic 
diseases.2 14 The Chronic Care model and Innovative 
Care for Chronic Conditions framework have been 
recommended as health system approaches to deal with 
multimorbidity.15 However, there have been significant 
resources and strategies allocated to the implementation 
of HIV programmes and consequently the non-commu-
nicable chronic diseases have been overlooked. To rectify 
this imbalance, the South African National Department 
of Health developed and has begun implementation of 
the Integrated Chronic Disease Management (ICDM) 
model in order to improve efficiencies and quality of care 
in primary healthcare clinics for patients with chronic 
diseases.16
Integrated Chronic disease Management model
The ICDM model was piloted from 2011 in 42 clinics 
from three health districts in three different provinces 
(figure 1) of South Africa as follows: West Rand in 
Gauteng Province, Bushbuckridge in Mpumalanga and 
Dr Kenneth Kaunda in North West Province.17 18 As part 
of a broader national approach to revitalise primary 
healthcare (PHC) services, reduce fragmentation of 
services and ensure that each PHC facility meets national 
minimum standards, the ‘ideal clinic’ initiative was also 
started in 2019.19 The principles of the ‘ideal clinic’ incor-
porate the majority of the activities required for ICDM 
implementation and provide standard operating proce-
dures for the Ideal Clinic Realisation and Maintenance 
(ICRM) programme.20 21 One of the components of the 
ICRM programme is Integrated Clinical Services Manage-
ment (ICSM), which focuses on health services being 
structured in four (acute, chronic, preventive and promo-
tive and health support) streams.20 21 The principles of 
the ICRM, ICSM and the ICDM model cover integration 
of services, good administrative processes, functional 
infrastructure and equipment, adequate personnel, 
ensuring adequate levels of medicines and supplies and 
the use of applicable protocols and guidelines in diseases 
management.19–21
The four major components (action points) of the 
ICDM implementation are as follows: facility reorgan-
isation for efficiency, clinical supportive management, 
assisted self-support and strengthening of support systems 
(figure 2).16 The ICDM priority and core standards are 
(1) improving the values and attitudes of staff, (2) patient 
safety and security and infection prevention and control 
and (3) availability of medicines and supplies.16 Assuming 
full implementation of the ICDM as recommended, the 
expected outcomes include improved operational effi-
ciency and quality of care, improved individual responsi-
bility towards their health and an activated and informed 
community.16 The ICDM model also provides guidelines 
on booking systems for patients with chronic diseases, 
clinic flow, organisation of waiting areas and consulta-
tion rooms and dispensing medication practices that 
promote adherence and minimise medication shortages. 
In order to avoid fragmentation of services, the ICDM 
recommends a multidisciplinary treating team to provide 
care to all patients with chronic illnesses and be trained 
on how to assess and manage drug-drug interactions 
and disease interactions. Mentoring, supervision and 
training of the PHC nurses to be provided by the district 
Clinical Specialist Team (DCST).16 The DCST's other 
responsibilities include monitoring of patient clinical 
outcomes through clinical audits and strengthening of 
referral systems for complicated patients.16 The compo-
nents or building blocks for ICDM model include human 
resources, health information, mobile technology, equip-
ment and pharmaceutical supply and management.16
ICdM model pilot phase implementation
The pilot phase was supported with quality improve-
ment reviews and consultation with all staff members 
at the facility, district and province levels to refine the 
model even further.18 Some of the implementation chal-
lenges identified in these consultations were lack of key 
equipment, an emphasis on curative health services with 
minimal focus on prevention, the ill-defined role of 
community healthcare workers and delayed formation of 
Figure 1 Map of South Africa with the Integrated Chronic 
Disease Management model pilot sites highlighted.
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out-of-facility chronic medication collection sites.18 Lack 
of these necessary building blocks for the ICDM model 
has resulted in the implementation of hybrids of the orig-
inal model.18 The limitations of the ICDM model identi-
fied include its focus on secondary and tertiary prevention 
of disease within the healthcare facilities and the lack of 
guidelines on social and environmental changes for the 
prevention of risk factors and onset of chronic diseases.16
Management of chronic conditions in PHC facilities
An evaluation of PHC services in South Africa showed 
low rates of diagnosis for chronic diseases, and the few 
that are diagnosed are not managed appropriately and 
do not achieve the treatment targets.22 23 The lack of key 
equipment in PHC clinics to diagnose and monitor total 
cholesterol, blood pressure and blood glucose contribute 
to these challenges, with patients reporting the need to 
travel to higher levels of care to access certain medica-
tion and diagnostic tests.22 Additional barriers included 
the insufficient consultation time that patients report 
with their healthcare providers even after long waiting 
periods at the facility due to high volumes of patients22; 
poor knowledge on chronic disease, shortage of medica-
tion and shortage of healthcare workers resulting in long 
waiting periods at PHC clinics.24 The nurses knowledge 
of chronic diseases was also found to be poor due to inad-
equate training, unavailability of guidelines and lack of 
supervision.24
The implementation of an innovative intervention can 
be affected by the design of the intervention, context and/
or implementation outcomes.25 New innovative interven-
tions could fail to achieve intended objectives because of 
implementation barriers or failures in the design.25 The 
Figure 2 Integrated Chronic Disease Management model.16
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observed impact of the ICDM model in the management 
of chronic diseases has been an improvement in the 
patients’ records, compliance with clinical guidelines and 
health outcomes for patients on antiretroviral medication 
but not those on hypertension treatment.26 27 Irregular 
supplies and stock-outs of hypertension medication were 
also not improved after the implementation of the ICDM 
model.28 The patients’ perspectives on the ICDM model 
inconveniences were a non-flexible appointment system 
that affected access to services, long waiting times because 
of personnel shortages and stigmatisation of patients that 
are visited by community healthcare workers.28 However, 
it is not clear whether these observed and perceived gains 
and shortcomings are as a result of the inherent faults 
in the design of the model or failure to adhere to the 
prescribed activities and/or the impact of contextual 
factors.
The successful implementation of the ICDM model 
requires a high degree of fidelity to the recommended 
processes of delivering healthcare services with clear 
intervention priorities and expected outcomes.29 30 
Although monitoring and evaluation tools exist for the 
ICDM model implementation, they do not provide data 
on implementation outcomes such as adoption, fidelity, 
penetration, acceptability, sustainability and costs. 
Process evaluation of the ICDM model implementation 
would optimise practice of the four major components 
and scale-up of the model, and the quality of care for indi-
viduals affected by chronic illness, especially those with 
multimorbidity.
Implementation of any intervention within a large 
complex health system is generally unpredictable. An 
assessment of fidelity on the implementation of the 
model will additionally measure quality of practice for 
continuous improvement, identify any innovations that 
can improve models’ processes and support systematic 
implementation of the model. Although the implemen-
tation of the ICDM model was subsequently followed by 
the ICRM programme that consists of the ICSM, which 
has a broader focus beyond chronic diseases, both these 
interventions have similar principles, standards and 
aims of ensuring that patients get quality patient-centric 
care that achieves the desired health outcomes.19–21 We 
envisage that lessons learned from an evaluation of the 
ICDM model can be beneficial in the strengthening of 
implementation of the ICRM programme.
Interviews with the actors in the ICDM model imple-
mentation will provide information on their perceptions 
and experiences with implementation and how contex-
tual factors have affected fidelity to the model’s guide-
lines. This can improve comparability, generalisability 
and replicability of the results of this study. Assessing the 
cost of implementing the various activities of the ICDM 
model will then assist with planning and budgeting, as 
well as inform scalability and sustainability of the model.
Therefore, the aim of this study is to evaluate selected 
implementation outcomes of the ICDM model: fidelity 
and implementation costs, and to assess the influence 
of contextual factors on ICDM model implementation 
fidelity in two health districts where the ICDM has been 
piloted, from two different provinces in order to better 
understand the processes of successful implementation of 
the ICDM model and how the model can be optimised. 
The objectives of the study are as follows:
1. To assess the degree of fidelity in the implementation 
of the ICDM model.
2. To evaluate the influence of contextual factors on the 
implementation fidelity of the ICDM model.




This study will be conducted from August 2018 to July 
2019 in two health districts (Dr Kenneth Kaunda in North 
West Province and West Rand District in Gauteng) that 
were the pilot sites for the ICDM model implementa-
tion. Both districts are within socioeconomic quantile 
4  (1 is most deprived and 5 is least deprived); however, 
comparing the North West to Gauteng province, poverty 
prevalence (33% vs 27%) and informal housing (21% vs 
19%) are  slightly higher in the North West Province.31 32 
The provincial HIV prevalence is 13.3% in North West 
Province and 12.4% in Gauteng.33 The prevalence of 
hypertension is high (31%–39.7%) in both districts, a 
reflection of large number of people accessing health 
services for chronic NCD.31 The prevalence of diabetes 
in South Africa is 8.27% (2.6 million) and 31.9% among 
adults (20–79 years), with 1.2 million people with diabetes 
estimated to be undiagnosed.34
theoretical framework
Process evaluation of complex interventions
Process evaluation frameworks assist in understanding 
the functioning of a complex intervention by reviewing 
implementation processes and the influence of contex-
tual factors.35 36 A complex intervention implementa-
tion process has multiple components, which interact to 
produce change, and/or are difficult to implement and/
or target a number of organisational levels.35 37 Process 
evaluation is therefore useful for assessing (figure 3) 
fidelity (dose, adaptations, frequency and reach), clar-
ifying the usual mechanisms and processes and identi-
fying the impact of contextual factors on the variations 
in processes and outcomes.38 A process evaluation 
framework will be applied in this study to evaluate 
whether the processes for implementing the interven-
tion (the ICDM model) are being applied as intended 
according to the design (fidelity) of the intervention 
and how contextual factors influence the implementa-
tion fidelity (figure 4). The costs, quantity and quality 
of programme activities provided and evaluating the 
generalisability of the results in other different contexts 
are important especially for a programme that is already 
established.38
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study design
This is a process evaluation study using mixed methods to 
assess the degree of fidelity, costs and impact of context 
on the implementation fidelity of the ICDM model.
objective-specific methodology
Fidelity assessment will be carried out to review if imple-
mentation of the ICDM model adheres to content, 
coverage, frequency and duration as prescribed in the 
ICDM model manual in 16  (8 in North West and 8 in 
Gauteng) clinics. As there are no fidelity criteria in the 
literature that are suitable to adapt for assessing the 
ICDM model implementation, we developed fidelity 
criteria based on the ICDM model guidelines,16 the ICRM 
programme monitoring tools21 and published literature 
on the ICDM model.18 26 28 30 The basis of the criteria 
are the four (facility reorganisation, clinical supportive 
management, assisted self-management and strength-
ening of the support systems) major components of the 
ICDM model.16 The outlined prescribed activities are the 
variables to be assessed on the implementation fidelity 
criteria. The expected outcome of the fidelity criteria 
is to warrant that all the essential activities required for 
successful implementation of the ICDM model have been 
captured. Each criterion under the four major compo-
nents will be listed as an item to be scored on the fidelity 
criteria. We will assess the fidelity criteria in a pilot study 
and finalise it on the basis of the results of the pilot study. 
Sixteen clinics from the 20 ICDM pilot clinics located in 
those districts will be considered for inclusion if the clinic 
has been open and running without any major interrup-
tions (renovations, closures) in the last 2 years. At each 
clinic, we will collect data using structured observations, 
review of facility records and interviews with the health-
care workers (table 1).
Contextual factors (facility characteristics and char-
acteristics of individuals and teams) on fidelity will be 
examined in four clinics. Based on the degree of fidelity, 
two clinics, one with a high and  one with a low degree 
Figure 3 The process evaluation framework for complex interventions.38
Figure 4 Modified process evaluation framework for assessing the fidelity and cost of the ICDM model 
implementation. ICDM, Integrated Chronic Disease Management.
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of fidelity, will be selected from each of the two districts. 
The organisational contextual factors to be considered 
include communication style, decision process and 
culture.39 Individual level data for the implementing 
teams will include demographics (age, gender, race, 
education level), position role within the clinic, years in 
that role and their participation in the delivery of the 
ICDM model. External (to the facility) context factors 
(socioeconomic level, policies and legislation) will not 
be evaluated in order to keep the study scope manage-
able. We will use mixed methods (interviews, facility 
assessments and culture surveys) approach to assess the 
influence of context on implementation fidelity. We will 
conduct qualitative interviews with 30 healthcare workers, 
purposively selected to represent different cadres of staff 
members that implement and manage the ICDM model 
intervention for more than 6 months (table 1). The inter-
views will be done on a one-to-one basis to minimise 
having group dynamics.
Participants’ confidentiality will be protected at all 
times during the study, and no electronic record will 
contain individual identifiers. A master list that contains 
the participants’ identifiers will be kept in a separate lock-
able area. The results will also be presented in such a way 
that respondents cannot be identified.
Costs
The financial and economic costs of implementing the 
ICDM model from the health system perspective will be 
evaluated in the same four clinics. The health system 
implementation costs are an all-inclusive costing valua-
tion that considers costs incurred by the providers of the 
service.40 Assessing the implementation costs will be a 
partial economic evaluation as it will only focus on the 
costs of implementation and not the outcomes. The unit 
of implementation costs will be by activity of each of the 
major components of the ICDM model. Service level costs 
such as those pertaining to the development of the ICDM 
model will not be included as these costs were incurred in 
2010/11. The focus will be on post start-up annual costs 
required for the full implementation of the ICDM model 
in a typical year (table 1). Both direct and indirect, and 
fixed and recurrent costs will be calculated.
Capital costs
Annualised equipment and capital costs will be calculated 
according to the volume being used for the ICDM model. 
Estimating annual costs will include adding up the acqui-
sition, operation, maintenance and disposal costs.
Operational costs
In the financial documents review, key operational 
costs that we will check and categorise include human 
resources, office supplies and travel. Based on the useful 
life and the discount rate, an appropriate annualisation 
factor will be determined. If there are any donations 
for programme implementation (volunteers, healthcare 
workers not allocated to ICDM but assisting in service 
Table 1 Summary of study objectives, methods and expected outcomes for assessing the fidelity, impact of contextual 
factors and costs of implementing the ICDM model 
Objective Methods Outcomes
Degree of fidelity 
assessment
To assess the degree 
of fidelity in the 
implementation of the 
ICDM model
Quantitative: fidelity evaluation in 16 ICDM 
model pilot PHC clinics using the fidelity 
criteria scoring checklist template.
Data sources: key informant interviews, 
structured observations and review of 
facility records
Degree of the ICDM model 
implementation fidelity for each 
activity and component of the 
ICDM model and overall scores 
by clinic and district
Impact of contextual 
factors on ICDM 
fidelity
To evaluate the influence 
of contextual factors on 
the implementation fidelity 
of the ICDM model
Qualitative interviews with 30 HCW in four 
(two per district) facilities using structured 
interview guides and organisational culture 
survey.
Quantitative data to assess association 
between contextual factors and degree of 
ICDM model fidelity
Health workers’ perceptions of 
contextual factors that influence 
implementation fidelity of the 
ICDM model.
Establish influence of contextual 





To estimate the 
implementation costs of 
the ICDM model
Ingredient approach to health system 
costs in four PHC clinics—two facilities 
per district using
The WHO CostIt software 2007.
Data sources: budgets, key informant 
interviews, direct observations and 
literature search.
Annualise capital costs
Adjust all costs for inflation and discount
Develop a cost profile for providing each 
component of the ICDM model
The cost of implementing each 
of the components of the ICDM 
model.
Sensitivity analysis to 
determine cost drivers in the 
implementation of the ICDM 
model.
ICDM, Integrated Chronic Disease Management ; PHC, primary healthcare. 
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delivery, donated equipment or office supplies), they will 
be included. Medical and support staff labour costs will 
be calculated based on the full-time equivalent, duration 
of involvement in the ICDM model implementation and 
the gross salary of the personnel.
A proportion of overhead costs of running the health 
facility like electricity, rent and water will be included in 
the implementation costs. Administrative costs at district 
and provincial level (which are beyond the facility) will 
not be included in the analysis.
Patient and public involvement
Previous research has shown that patients do not like 
some of the components of the ICDM model26 and that 
was the basis of the research question. Patients will not be 
enrolled in the study; however, results will be shared with 
them through community and health facilities leadership.
data management and analysis plan
The data will be collected using paper-based question-
naires and later captured into an electronic database. 
There will be no identifying features (eg, date of birth, 
addresses) in the database. The health facilities and 
healthcare workers that participated will be allocated a 
study number. Source documents will be safely kept and 
only accessible to study personnel. The data on costs 
will be manually entered into the CostIt software 200741 
according to the provided major categories. CostIt soft-
ware is a template designed to capture and automati-
cally analyse cost data for different (hospital, PHC and 
programme) levels of the healthcare system.41
Descriptive statistics (frequency, median, interquartile 
ranges and percentages) will be used to examine the 
general quantitative variables of the clinics, such as size, 
number of chronic patients, services offered, clinic team 
characteristics and overall functioning status. Following 
the evaluation, each clinic will receive a score for each 
of the fidelity criteria items. Item scores will be summed 
per component to give four overall ICDM component 
fidelity scores per facility. An overall ICDM model imple-
mentation fidelity score will be calculated per facility by 
summing the four component scores. The implementa-
tion fidelity scores will be summarised using descriptive 
statistics and compared between components, facilities 
and districts. The outcome of interest will be the degree 
of implementation fidelity.
The experiences and perceptions of the healthcare 
workers from the interviews will be analysed with REDCap 
software for Likert scaled questions and using thematic 
content analysis for barriers and facilitators of implemen-
tation fidelity for qualitative data. The six steps recom-
mended by Braun and Clarke42 for thematic content 
analysis that will be followed: familiarisation, generating 
initial codes, searching for themes throughout the data-
base, reviewing and naming themes and summarising the 
findings.42 Multivariate analysis using STATA V.14 econo-
metric software will be used to assess the effect of various 
contextual factors on the implementation fidelity of the 
ICDM model. The impact of both the organisational 
(case mix, financial flexibility and culture) and imple-
menting team (work experience, cadre of HCW, training 
and perceptions of ICDM) level factors on the degree of 
the ICDM model implementation fidelity will be assessed. 
The initial analysis will include description of the sample, 
followed by a bivariate analysis that includes t-tests and 
ANOVA to examine the influence of contextual factors 
on implementation fidelity of the ICDM model.
Costs: Capital costs and other costs that have a life span 
of several years will be annualised over the useful life span 
to get the equivalent annual costs. All costs will be adjusted 
for inflation and discount. Equipment will be depreciated 
according to the South African Accounting principles.43 
Sensitivity analyses will be conducted for other possible 
variations in estimated costs. Sensitivity analyses will also 
be carried out to explore different scenarios including 
size of clinic, degree of implementation fidelity and other 
factors that could possibly affect costs based on literature.
Ethics and dissemination
Ethical conduct of the study
This study has been approved by the University of Cape 
Town (Ref: 127/2018) and University of the Witwa-
tersrand (Ref: R14/49) Human Research ethics commit-
tees. Approvals have also been received from the Gauteng 
and the North West Provincial Department of Health. 
The participants for the interviews will be consented indi-
vidually prior to taking part in the study.
Dissemination of the results
The results of this study will be shared with the various 
stakeholders to inform the implementation of the ICDM 
model in South Africa and other models of integrated 
care. Brief summary of results will be presented to the 
provincial and districts departments of health (DOH). 
The full results will be presented at local research days 
in each province and district. Facility managers and local 
clinic staff that participated in the study will be given feed-
back on the outcomes of the study. The results will also be 
presented through publications and conference presen-
tations to enhance scientific knowledge. Authorship will 
be determined by substantial contributions to the study 
according to the recommendations for the conduct, 
reporting and publication of research in medical jour-
nals. Once the data collection and cleaning are complete, 
it will be made open and publicly accessible.
ConClusIon
Many health systems are challenged with increased 
demand for healthcare for chronic diseases. Despite this 
service need, there is minimal integration of services for 
the management of chronic diseases resulting in ineffi-
ciencies in service delivery, high costs and poor health 
outcomes. The ICDM model has been developed to 
address this challenge, the success of which will be influ-
enced by the degree to which the model is accurately 
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implemented. This highlights the need for data to assess 
the degree of fidelity to the ICDM model intervention 
and for data that explore how fidelity of implementation 
is affected by contextual factors. Data generated from 
this study will inform integration of chronic care services 
at the PHC level and scalability of the ICDM model, of 
relevance in South Africa and other low-income and 
middle-income countries increasingly facing a growing 
tide of chronic disease multimorbidity.
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